(Q43064346)

13 November 2017

title

Evaluation of promoter hypermethylation detection in serum as a diagnostic tool for breast carcinoma in Korean women (English)

1 reference

13 November 2017

1 reference

1 reference

0 references

3

Sun-Seog Kweon

1 reference

13 November 2017

Jo-Heon Kim

1

1 reference

13 November 2017

Min-Ho Shin

2

1 reference

13 November 2017

Min Ho Park

4

1 reference

13 November 2017

Jung Han Yoon

5

1 reference

13 November 2017

Ji Shin Lee

6

1 reference

13 November 2017

Chan Choi

7

1 reference

13 November 2017

Mary Jo Fackler

8

1 reference

13 November 2017

Saraswati Sukumar

9

1 reference

13 November 2017

language of work or name

English

0 references

publication date

13 May 2010

1 reference

13 November 2017

1 reference

13 November 2017

volume

118

1 reference

13 November 2017

issue

2

1 reference

13 November 2017

page(s)

176-181

1 reference

Chronological changing patterns of clinical characteristics of Korean breast cancer patients during 10 years (1996-2006) using nationwide breast cancer registration on-line program: biannual update.

13 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.04.016

Detection of ductal carcinoma in situ in women undergoing screening mammography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.04.016

Ten-year risk of false positive screening mammograms and clinical breast examinations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.04.016

Limitations of mammography in Chinese females

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.04.016

DNA methylation and gene silencing in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.04.016

Aberrant methylation of the CDKN2a/p16INK4a gene promoter region in preinvasive bronchial lesions: a prospective study in high-risk patients without invasive cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.04.016

Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.04.016

Sensitive Detection of DNA Methylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.04.016

Quantitative multiplex methylation-specific PCR analysis doubles detection of tumor cells in breast ductal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.04.016

Quantitative promoter hypermethylation profiles of ductal carcinoma in situ in North American and Korean women: Potential applications for diagnosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.04.016

Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.04.016

Methylated genes as new cancer biomarkers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.04.016

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.04.016

Aberrant DNA methylation of the p16INK4a gene in plasma DNA of breast cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.04.016

Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.04.016

Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.04.016

Detection of RASSF1A and RARbeta hypermethylation in serum DNA from breast cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.04.016

Promoter hypermethylation of TMS1, BRCA1, ERalpha and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.04.016

Promoter hypermethylation of p16INK4A, p14ARF, CyclinD2 and Slit2 in serum and tumor DNA from breast cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.04.016

Quantitative detection of methylated ESR1 and 14-3-3-sigma gene promoters in serum as candidate biomarkers for diagnosis of breast cancer and evaluation of treatment efficacy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.04.016

Multigene methylation in serum of sporadic Chinese female breast cancer patients as a prognostic biomarker

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.04.016

Association between folate-metabolizing pathway polymorphism and non-Hodgkin lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.04.016

DNA methylation and breast carcinogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.04.016

Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.04.016

10.1016/J.YGYNO.2010.04.016

7 January 2021

Identifiers

DOI

1 reference

13 November 2017

1 reference